Birmingham, West Midlands -- (SBWIRE) -- 10/23/2013 -- Value Penny Stocks issues special report on ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Forest Oil Corporation (NYSE:FST), Anworth Mortgage Asset Corporation (NYSE:ANH), MannKind Corporation (NASDAQ:MNKD).
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) opened its last trade at the price of $4.77. Its closing price was $4.93 after gaining 4.01% for the day. The company traded with the total volume of 1.09 million shares, while its average trading volume remained 1.11 million shares. The beta of this stock stands at 1.72. ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the discovery and development of new cancer therapies. The company is employing novel gene expression and control technology to deliver DNA for the treatment of cancer.
For How Long ZIOP will Fight for Profitability? Read This Trend Analysis report
Forest Oil Corporation (NYSE:FST) percentage change plunged -9.14% to close at $4.97 with the total traded volume of 12.26 million shares, along with average volume of 4.94 million shares. The 52 week range of the stock remained $3.77 - $8.80, while its day lowest price was $4.83. The share price hit the day highest price of $5.30. Forest Oil Corporation, an independent oil and gas company, engages in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids primarily in North America.
Has FST Found The Bottom And Ready To Gain Momentum? Find Out Here
Anworth Mortgage Asset Corporation (NYSE:ANH) traded on volume of 4.51 million shares in the last session against average volume of 1.22 million shares. The company started its trading session with the price of $4.73 and closed at $5.05 by scoring +7.22%. Anworth Mortgage Asset Corporation operates as a real estate investment trust in the United States. The company primarily invests in the United States agency mortgage-backed securities.
Will ANH Continue To Move Higher? Find Out Here
MannKind Corporation (NASDAQ:MNKD) started its last trading session with the price of $5.12 and closed at $5.16 by scoring +0.58%. The stock traded with total volume of 2.71 million shares, while the average trading volume remained 5.04 million shares. The beta value of this stock stands at 1.63. Day range for the stock was $4.99 - $5.19. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Why Should Investors Buy MNKD After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)